| MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition D Horiuchi, L Kusdra, NE Huskey, S Chandriani, ME Lenburg, ... Journal of Experimental Medicine 209 (4), 679-696, 2012 | 382 | 2012 |
| PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression D Horiuchi, R Camarda, AY Zhou, C Yau, O Momcilovic, S Balakrishnan, ... Nature medicine 22 (11), 1321-1329, 2016 | 159 | 2016 |
| Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis E Raderschall, A Bazarov, J Cao, R Lurz, A Smith, W Mann, HH Ropers, ... Journal of cell science 115 (1), 153-164, 2002 | 131 | 2002 |
| Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells EM Weissinger, G Eissner, C Grammer, S Fackler, B Haefner, LS Yoon, ... Molecular and cellular biology 17 (6), 3229-3241, 1997 | 85 | 1997 |
| A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation AV Bazarov, S Adachi, SF Li, MK Mateyak, S Wei, JM Sedivy Cancer research 61 (3), 1178-1186, 2001 | 56 | 2001 |
| Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies R Mukhopadhyay, SV Costes, AV Bazarov, WC Hines, MH Barcellos-Hoff, ... Breast Cancer Research 12, 1-15, 2010 | 41 | 2010 |
| p16INK4a‐mediated suppression of telomerase in normal and malignant human breast cells AV Bazarov, M Van Sluis, WC Hines, E Bassett, A Beliveau, E Campeau, ... Aging cell 9 (5), 736-746, 2010 | 38 | 2010 |
| Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes AV Bazarov, WC Hines, R Mukhopadhyay, A Beliveau, S Melodyev, ... Cell Cycle 8 (20), 3373-3378, 2009 | 37 | 2009 |
| BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas WC Hines, AV Bazarov, R Mukhopadhyay, P Yaswen PLoS One 5 (3), e9738, 2010 | 31 | 2010 |
| Host cells with artificial endosymbionts CB Bell III, A Bazarov US Patent 8,828,681, 2014 | 30 | 2014 |
| The specific role of pRb in p16INK4A-mediated arrest of normal and malignant human breast cells AV Bazarov, WJ Lee, I Bazarov, M Bosire, WC Hines, B Stankovich, ... Cell cycle 11 (5), 1008-1013, 2012 | 28 | 2012 |
| Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors AV Bazarov, P Yaswen Breast Cancer Research 13, 1-2, 2011 | 23 | 2011 |
| A Simple Three-dimensional Hydrogel Platform Enables Ex Vivo Cell Culture of Patient and PDX Tumors for Assaying Their Response to Clinically Relevant … KC Hribar, CJ Wheeler, A Bazarov, K Varshneya, R Yamada, P Buckley, ... Molecular cancer therapeutics 18 (3), 718-725, 2019 | 21 | 2019 |
| Host cells with artificial endosymbionts CB Bell III, AV Bazarov US Patent 8,956,873, 2015 | 20 | 2015 |
| Host cells with artificial endosymbionts CB Bell III, A Bazarov US Patent 8,859,281, 2014 | 19 | 2014 |
| Host cells with artificial endosymbionts CB Bell III, A Bazarov US Patent 8,859,281, 2014 | 19 | 2014 |
| Host cells with artificial endosymbionts CB Bell III, A Bazarov US Patent 8,859,281, 2014 | 19 | 2014 |
| Host cells with artificial endosymbionts CB Bell III, A Bazarov US Patent 8,859,281, 2014 | 19 | 2014 |
| Eukaryotic cells with artificial endosymbionts for multimodal detection CB Bell III, A Bazarov US Patent 9,023,612, 2015 | 17 | 2015 |
| A tumor-suppressing function in the epithelial adhesion protein Trask DS Spassov, CH Wong, G Harris, S McDonough, P Phojanakong, ... Oncogene 31 (4), 419-431, 2012 | 17 | 2012 |
Andrei GogaProfessor and Vice-Chair of Cell & Tissue Biology and Medicine, UCSFVerified email at ucsf.edu
